[Atrial natriuretic peptide for therapy of heart failure].
Takeda
Norifumi
N
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D004730:Endothelium, Vascular / Q000166:cytology; D006162:Guanylate Cyclase / Q000502:physiology; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D017461:Receptors, Atrial Natriuretic Factor / Q000502:physiology; D012084:Renin-Angiotensin System / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D009320:Atrial Natriuretic Factor; D000324:Adrenocorticotropic Hormone; D006162:Guanylate Cyclase; D017461:Receptors, Atrial Natriuretic Factor; C091715:atrial natriuretic factor receptor A